Skip to main content

Hidradenitis Suppurativa Derm Q&A

Melissa Weiss, Associate Editor
Findings from a recent study showed patients with HS have a similar incidence to other well-studied, at-risk patient groups of opioid use, including those with newly diagnosed musculoskeletal pain. Lead study author Sarah Reddy discusses the implications of these findings and the role dermatologists play in identifying patients at-risk for opioid misuse.
Melissa Weiss, Associate Editor
Hidradenitis suppurativa (HS) is a painful skin condition, which a recent study showed was associated with both nociceptive pain and neuropathic pain. Corresponding authors Rikke M. Nielsen, MD, with the University of Southern Denmark, and Pernille Lindsø Andersen, MD, with the University of Copenhagen, discussed how these findings can affect treatment of pain among patients with HS in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
A poster study showed patients with hidradenitis suppurativa are comfortable discussing sexual health concerns with dermatologists. Andrea Murina, MD, corresponding author of the study, discusses the results and how dermatologists can improve patients’ comfort levels during clinical exams.
Back to Top